Phox2a in Lateral Spinal Nucleus Tac1 ‐Positive Neurons Mediates Histamine‐Independent Acute Itch
CNS Neuroscience & Therapeutics · 2025-11 · 31 (11)
DOI: 10.1111/cns.70639 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 07.11.2025. Verfasst von Yu-Ling Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Anatomy and Histology and Embryology, School of Basic Medical Sciences, The Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Pruritus, Neurons, Homeodomain Proteins, Tachykinins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, STI2030-Major Projects, Scientific Research Fund of Baotou Medical College.
Abstract (Originalsprache)
Aims
While acute itch comprises histamine‐dependent and ‐independent subtypes, critical mechanisms underlying histamine‐independent itch remain poorly understood. This study investigates the role of paired‐like homeobox 2a (Phox2a) in tachykinin 1‐positive (Tac1 + ) neurons of the lateral spinal nucleus (LSN) as a novel target for histamine‐independent pruritus intervention.
Methods
We combined chemogenetic manipulation (viral‐mediated neuronal activation/inhibition), whole‐cell patch‐clamp recordings, immunohistochemistry, fluorescence in situ hybridization, Western blotting, and behavioral assays to investigate the role of LSN Tac1 neurons and Phox2a in itch modulation.
Results
LSN Tac1 neurons were specifically activated during chloroquine (CQ)–induced histamine‐independent itch. Chemogenetic activation of these neurons exacerbated scratching, whereas inhibition suppressed itch behavior. Notably, Phox2a, expressed in LSN Tac1 neurons, was downregulated during CQ‐induced itch. Overexpression of Phox2a in LSN Tac1 neurons significantly alleviated CQ‐evoked scratching and was accompanied by a reduction in spontaneous excitatory postsynaptic currents (sEPSCs) amplitude without a change in sEPSCs frequency.
Conclusions
Our findings identify Phox2a in LSN Tac1 neurons as a selective regulator of histamine‐independent acute itch through presynaptic excitability. This highlights Phox2a as a novel therapeutic target for histamine‐independent pruritus intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Anatomy and Histology and Embryology, School of Basic Medical Sciences, The Fourth Military Medical University, Xi'an, China.
- Department of Human Anatomy, Baotou Medical College, Baotou, China.
- Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
- Department of Anatomy, College of Basic Medicine, Dali University, Dali, China.
ORCID-Profile: Zhen-Zhen Kou
Förderung
- National Natural Science Foundation of China
- STI2030-Major Projects
- Scientific Research Fund of Baotou Medical College
- Joint Founding Project of Innovation Research Institute of Xijing Hospital
Zitieren
APA
Chen, Y. L., Li, Z. A., Wang, Q. Z., Wu, X. R., Mao, E., Liu, Y. H., Cai, Z. P., Li, Y. Q., & Kou, Z. Z. (2025). Phox2a in Lateral Spinal Nucleus Tac1 ‐Positive Neurons Mediates Histamine‐Independent Acute Itch. CNS Neuroscience & Therapeutics, 31(11). https://doi.org/10.1111/cns.70639
Vancouver
Chen YL, Li ZA, Wang QZ, Wu XR, Mao E, Liu YH, et al. Phox2a in Lateral Spinal Nucleus Tac1 ‐Positive Neurons Mediates Histamine‐Independent Acute Itch. CNS Neuroscience & Therapeutics. 2025;31(11). doi:10.1111/cns.70639
BibTeX
@article{Chen2025,
author = {Chen, Yu-Ling and Li, Zi-Ang and Wang, Qing-Zhen and Wu, Xin-Ran and Mao, E and Liu, Yao-Hua and Cai, Zhi-Ping and Li, Yun-Qing and Kou, Zhen-Zhen},
title = {Phox2a in Lateral Spinal Nucleus Tac1 ‐Positive Neurons Mediates Histamine‐Independent Acute Itch},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {11},
doi = {10.1111/cns.70639}
}
EUVIMED